FDA clears Smith & Nephew's bone cement:
This article was originally published in Clinica
Executive Summary
Smith & Nephew's Orthopaedic division has received US FDA 510(k) clearance for its VersaBond medium density viscosity bone cement. The product can be used in shoulder, hip and knee replacement procedures and is the first bone cement to be cleared under the 510 (k) process since the products were reclassified from a Class III to Class II device under FDA guidelines, says the company.